BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26552140)

  • 1. [Eukaryotic elongation factor 2 kinase and cancer].
    Wang GZ; Qi X; Li J
    Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
    Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
    Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.
    Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE
    Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
    Fu LL; Xie T; Zhang SY; Liu B
    Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
    Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
    Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
    Bianco C; Thompson L; Mohr I
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions.
    Rose AJ; Alsted TJ; Jensen TE; Kobberø JB; Maarbjerg SJ; Jensen J; Richter EA
    J Physiol; 2009 Apr; 587(Pt 7):1547-63. PubMed ID: 19188248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts.
    Kameshima S; Okada M; Yamawaki H
    Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.
    Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner.
    Smith EM; Proud CG
    EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
    Liu R; Proud CG
    Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
    Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
    Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease.
    Ma T
    J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase.
    Hong-Brown LQ; Brown CR; Huber DS; Lang CH
    J Cell Biochem; 2008 Oct; 105(3):814-23. PubMed ID: 18712774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation.
    Kaul G; Pattan G; Rafeequi T
    Cell Biochem Funct; 2011 Apr; 29(3):227-34. PubMed ID: 21394738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.
    Zhang B; Zou J; Zhang Q; Wang Z; Wang N; He S; Zhao Y; Naman CB
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia.
    McCamphill PK; Ferguson L; Sossin WS
    J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis.
    Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal injury activates the eEF2K-dependent eEF2 pathway in pediatric patients.
    Song J; Finnerty CC; Herndon DN; Kraft R; Boehning D; Brooks NC; Tompkins RG; Jeschke MG
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):596-602. PubMed ID: 22269896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
    De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
    EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.